how are people buying retatrutide and the Grey Market: Buyer Beware – Sarah Hormachea Newsflash: if you are buying

We are tackling several of the industrys unanswered questions, one data point at a time, to develop a deeper understanding of some of the scientific pathways driving our diseases of focus, as well as studying additional modalities to make targeting those pathways possible

Overall, we found no signal that longer follow-up modifies the comparative risk of VTE, but dedicated long-term head-to-head studies remain needed

NICE has issued specific guidance on its use in type 2 diabetes

The third criterion for establishing a device category, at 419.66(c)(3), requires CMS to determine that the cost of the device is not insignificant, as described in 419.66(d)

In 2025, obesity remains one of the most critical health crises in the United States, affecting more than 40 percent of U.S